Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
LEXX
Stock Latest News
Company Announcements
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
4d ago
LEXX
Premium
The Fly
Lexaria Bioscience to begin new human clinical study in GLP-1
4d ago
LEXX
Premium
Company Announcements
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
10d ago
LEXX
Premium
The Fly
Lexaria receives five new patents, including two for diabetes treatment
10d ago
LEXX
Premium
Company Announcements
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
12d ago
LEXX
Premium
Company Announcements
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
1M ago
LEXX
Premium
The Fly
Lexaria Bioscience announces 2026 R&D plans
1M ago
LEXX
Premium
Company Announcements
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
2M ago
LEXX
Premium
The Fly
Lexaria announces final results from GLP-1-H25-5 study
2M ago
LEXX
Premium
Company Announcements
Lexaria Bioscience Shareholders Endorse Directors and Auditors
2M ago
8K
LEXX
Premium
Company Announcements
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
2M ago
LEXX
Premium
The Fly
Lexaria Bioscience awarded six additional patents
2M ago
LEXX
Premium
Company Announcements
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
3M ago
LEXX
Premium
The Fly
Lexaria CEO says ‘closer to a commercial breakthrough than ever before’
3M ago
LEXX
Premium
Company Announcements
Lexaria’s Phase 1b GLP-1 Study Shows Comparable Metabolic Outcomes and Encouraging Blood Pressure Data for DehydraTECH Platform
3M ago
LEXX
Premium
The Fly
Lexaria releases additional results from Phase 1b study GLP-1-H24-4
3M ago
LEXX
Premium
The Fly
Lexaria Bioscience files to sell 2.75M shares of common stock for holders
3M ago
LEXX
Premium
Company Announcements
Lexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
3M ago
LEXX
Premium
The Fly
Lexaria Bioscience achieves primary endpoint in Phase 1b study GLP-1-H24-4
3M ago
LEXX
Premium
Company Announcements
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
4M ago
LEXX
Premium
The Fly
Lexaria Bioscience prices 2.66M share at the market offering at $1.315
4M ago
LEXX
Premium
Company Announcements
Lexaria Extends Agreement to Advance Drug Delivery Technology Evaluation
5M ago
LEXX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
